HHBT | HH Biotechnology Holdings Company Annual &

Annual Income Statements

(In USD)

Breakdown	2015
Revenue	7.99 Million
Cost of Revenue	5.63 Million
Gross Profit	2.35 Million
Operating Expenses	-745.35 Thousand
Selling, General and Administrative Expenses	-
Research and Development Expenses	-
Other Expenses	745.35 Thousand
Cost and Expenses	5.76 Million
Operating Income	3.09 Million
Interest Expense	874.32 Thousand
Income Tax Expense	230.99 Thousand
Earnings before Tax	2.65 Million
Net Income	2.47 Million
Earnings Per Share Basic	0.18
Earnings Per Share Diluted	0.18
Weighted Average Shares Outstanding	13.51 Million
Weighted Average Shares Outstanding (Diluted)	13.51 Million
Gross Margin	0.29
EBIT Margin	0.79
Profit Margin	0.31
EBITDA	5.44 Million
Earnings Before Tax Margin	0.39

Breakdown	2015 FY
Revenue	7.99 Million
Cost of Revenue	5.63 Million
Gross Profit	2.35 Million
Operating Expenses	-745.35 Thousand
Selling, General and Administrative Expenses	-
Research and Development Expenses	-
Other Expenses	745.35 Thousand
Cost and Expenses	5.76 Million
Operating Income	3.09 Million
Interest Expense	874.32 Thousand
Income Tax Expense	230.99 Thousand
Earnings before Tax	2.65 Million
Net Income	2.47 Million
Earnings Per Share Basic	-
Earnings Per Share Diluted	-
Weighted Average Shares Outstanding	13.51 Million
Weighted Average Shares Outstanding (Diluted)	13.51 Million
Gross Margin	0.29
EBIT Margin	-
Profit Margin	0.31
EBITDA	-
Earnings Before Tax Margin	0.39